Advances in Gaucher Disease 3 Advances in Gaucher Disease Author Guidelines Scope of Manuscripts Advances in Gaucher Disease considers the following types of manuscripts for publication: • Reviews that summarize and synthesize peer-reviewed literature to date on relevant topics in a scholarly fashion and format. • Original contributions based on original, basic, clinical, translational, epidemiological, or prevention studies relating to Gaucher Disease that are well documented, novel, and significant. • Letters to the Editor on timely and relevant subjects pertaining to the diagnosis and treatment of Gaucher Disease. • Clinical case studies. Manuscript Submission Authors are required to submit their manuscripts in an electronic format, preferably by email to the Executive Editor, Stu Chapman, at stulink@aol.com. Please provide in a word processing program. Images should be submitted electronically as well. All material reproduced from previously published, copyrighted material should contain a full credit line acknowledging the original source. The author is responsible for obtaining this permission. Contact information List all authors, including mailing address, titles and affiliations, phone, fax, and email. Please note corresponding author. Peer Review and Editing Manuscripts will be peer reviewed. Accepted manuscripts will be edited for clarity, spelling, punctuation, grammar, and consistency with American Medical Association (AMA) style. Authors whose manuscripts are not initially accepted may have the opportunity to revise the manuscript based on recommendations from peer reviewers and at the discretion of the Editor-in-Chief. Conflict of Interest Advances in Gaucher Disease policy requires that authors reveal to the Editor-in-Chief any relationships that they believe could be construed as resulting in an actual, potential, or apparent conflict of interest with regard to the manuscript submitted for review. Authors must disclose this information in the covering letter accompanying their submission. Manuscript Preparation Length: Full-length manuscripts should not exceed 4000 words, including references. Please limit the reference list to 50 citations. Manuscripts should be accompanied by figures and/or tables. Generally 4-5 figures and 2-3 tables are preferred for each manuscript. Please include a brief description to accompany these items, as well as a legend for all abbreviations. Manuscripts should not contain an abstract but an introduction is recommended. Spacing: One space after periods. Manuscripts should be double spaced. References All submissions should have references that are referred to in the text by superscripted numbers and that conform to AMA style. Example: Lewczuk J, Piszko P, Jagas J, et al. Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest. 2001;119:818-823. Copyright Manuscripts and accompanying material are accepted for exclusive publication in Advances in Gaucher Disease. None of the contents may be reproduced without permission of Advances in Gaucher Disease. To request permission, please contact Stu Chapman, Executive Editor, (516) 356-5006; email: stulink@aol.com.
19984GA
To see the actual publication please follow the link above